Your search history is turned on.
Date: April 25, 2024 18:06:38 EST Jurisdictions: All jurisdictions
VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS MONTREAL, April 25, 2024 /CNW/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 2...
Date: April 9, 2024 Jurisdictions: All jurisdictions
VALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE VALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE MONTREAL, April 9, 2024 /CNW/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced that Steve Saviuk, Valeo's Chief Executive Officer, will present an...
Date: April 1, 2024 Jurisdictions: All jurisdictions
1 We are sending to you the enclosed proxy-related materials that relate to a meeting of the holders of the series or class of securities that are held on your behalf by the intermediary identified above. Unless you attend the meeting and vote in person, your securities can be voted only by management, as proxy holder of the registered holder, in accordance with your instruction...
Notes to proxy 1. Every holder has the right to appoint some other person or company of their choice, who need not be a holder, to attend and act on their behalf at the meeting or any adjournment or postponement thereof. If you wish to appoint a person or company other than the Management Nominees whose names are printed herein, please insert the name of your chosen proxyhold...
_ 1 VALEO PHARMA INC. NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS AND MANAGEMENT INFORMATION CIRCULAR Dated: March 22, 2024 These materials are import...
_ 2 NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS To the shareholders of Valeo Pharma Inc. (the Corporation): NOTICE IS HEREBY GIVEN THAT an annual general meeting of shareholders (the Meeting) of the Corporation will be held on Thursday, April 25, 2024 at 10:30 a.m. (Eastern time) at the offices of Valeo Pharma Inc. at 16667, Hymus Blvd., Kirkland...
Date: March 22, 2024 Jurisdictions: All jurisdictions
VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORS VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORS MONTREAL, March 22, 2024 /CNW/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced that Mr. Al Moghaddam has joined the Company's Board of Directors. "We are ver...
Date: March 15, 2024 Jurisdictions: All jurisdictions
Financial Report First Quarter Fiscal Year 2024 January 31, 2024 VALEO PHARMA INC. Managements Discussion and Analysis for the three-month period ended January 31, 2024 1 MANAGEMENTS RESPONSIBILITY FOR FINANCIAL REPORTING The following is Managements Discussion and Analysis (MD&A) of...
Interim Condensed Consolidated Financial Statements (Unaudited) Valeo Pharma Inc. January 31, 2024 First quarter fiscal year 2024 Valeo Pharma Inc. Interim Condensed Consolidated Statements of Financial Position (Unaudited) (All...